22.03.2013 - European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)